Director of the Institute of Chemical Biology Profile

Dr. Stathis Gonos

Director of the Institute of Chemical Biology
National Hellenic Research Foundation (NHRF)
48 Vassileos Constantinou Avenue
11635 Athens, Greece

Tel.: +30 210.72.73.756
email: [email protected] | [email protected]

Dr Stathis Gonos is the Director of the Institute of Chemical Biology at the National Hellenic Research Foundation. He graduated from the Department of Pharmacy, University of Athens, Greece, obtained his Ph.D. at the Department of Biochemistry, University of Glasgow, Britain and a Docent in Biomedicine at the Orebro University, Medical School, Sweden. He worked at the Ludwig Institute for Cancer Research/University College in London, Britain and he has been the General Director of the Hellenic Pasteur Institute.

His research focuses on the genetic and environmental factors that are linked to human aging and longevity. He has published more than 150 research articles, is author of 14 monographs and patents’ holder that have resulted in the development of novel anti-aging products.

Dr. Gonos has been a ''Senior expert'' of E.U. in ''Human development and the aging process'' and Deputy National Representative of Greece in E.U. in ''Genomics and Biotechnology for Health''. He is past member of the Executive Committee of International Union of Biochemistry and Molecular Biology (IUBMB), the Advanced Course Committee of Federation of European Biochemical Societies (FEBS) and the Board of Directors of the ''Society of Free Radicals Research-Europe''. He is currently member of the Board of Directors of the “European Society of Antiaging Medicine”. He is Editor-in-Chief of “Mechanisms of Ageing & Development” (IF 5.1) and “IUBMB Life” (IF 3.2) and Editorial Board member of “Ageing Research Reviews”, “Antioxidants”, “Experimental Gerontology”, “Free Radicals in Biology & Medicine”, “Free Radicals Research”, “Aging Cell” (-2007), “Biogerontology” (-2009), “Gerontology” (-2023), “Molecular Aspects of Medicine” (-2016) and “Redox Biology” (-2024).